Antiviral profiling of C-18-or C-19-functionalized semisynthetic Abietane diterpenoids (Record no. 55084)

MARC details
000 -LEADER
fixed length control field 02029nam a2200241Ia 4500
003 - CONTROL NUMBER IDENTIFIER
control field MX-MdCICY
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250625162459.0
040 ## - CATALOGING SOURCE
Transcribing agency CICY
090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (RLIN)
Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) B-21006
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 250602s9999 xx |||||s2 |||| ||und|d
245 10 - TITLE STATEMENT
Title Antiviral profiling of C-18-or C-19-functionalized semisynthetic Abietane diterpenoids
490 0# - SERIES STATEMENT
Volume/sequential designation Journal of Natural Products, 85(8), p.2044-2051, 2022
520 3# - SUMMARY, ETC.
Summary, etc. Viral infections affect several million patients annually.Although hundreds of viruses are known to be pathogenic, only a few can be treated in the clinic with available antiviral drugs. Naturally based pharmacotherapy may be a proper alternative for treating viral diseases.Several natural and semisynthetic abietane-type diterpenoids have shown important antiviral activities. In this study, a biological evaluation of a number of either C-18- or C-19-functionalized known semisynthetic abietanes against Zika virus, Dengue virus, Herpes virus simplex type 1, and Chikungunya virus are reported. Semisynthetic abietane ferruginol and its analogue 18-(phthalimid-2-yl)ferruginol displayed broad-spectrum antiviral properties. The scale-up synthesis of this analogue has been optimized for further studies and development. This molecule displayed an EC50 between 5.0 and 10.0 ?M against Colombian Zika virus strains and EC50 = 9.8 ?M against Chikungunya virus. Knowing that this ferruginol analogue is also active against Dengue virus type 2 (EC50 = 1.4 ?M, DENV-2), we can conclude that this compound is a promising broad-spectrum antiviral agent paving the way for the development of novel antivirals.
700 12 - ADDED ENTRY--PERSONAL NAME
Personal name González-Cardenete, M. A.
700 12 - ADDED ENTRY--PERSONAL NAME
Personal name Hamulic, D.
700 12 - ADDED ENTRY--PERSONAL NAME
Personal name Miquel-Leal, F. J.
700 12 - ADDED ENTRY--PERSONAL NAME
Personal name González-Zapata, N.
700 12 - ADDED ENTRY--PERSONAL NAME
Personal name Jimenez-Jarava, O. J.
700 12 - ADDED ENTRY--PERSONAL NAME
Personal name Brand, Y. M.
700 12 - ADDED ENTRY--PERSONAL NAME
Personal name Marín, M. L.
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://drive.google.com/open?id=1VW4MY8sWRhORrlyjOGdmzaA_N9M8ooO_&usp=drive_copy">https://drive.google.com/open?id=1VW4MY8sWRhORrlyjOGdmzaA_N9M8ooO_&usp=drive_copy</a>
Public note Para ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Clasificación local
Koha item type Documentos solicitados
Holdings
Lost status Source of classification or shelving scheme Damaged status Not for loan Collection Home library Current library Shelving location Date acquired Total checkouts Full call number Date last seen Price effective from Koha item type
  Clasificación local     Ref1 CICY CICY Documento préstamo interbibliotecario 25.06.2025   B-21006 25.06.2025 25.06.2025 Documentos solicitados